Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or Hypnotherapy
Key facts
- Who runs it
- Institut Cancerologie de l'Ouest
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 21 people enrolled
- Started
- 29 Sept 2021
- Ended
- 29 Mar 2024
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Motivational Interviewing (MI)
- Cognitive Behavioural Therapy (CBT)
- Hypnotherapy
- Nicotine Replacement Therapy (NRT)
- Record updated
- 7 August 2026
- Why it stopped
- lack of patient enrolment
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Age ≥ 18 years
- Smoking patient: daily tobacco consumption
- Patient with cancer requiring surgical treatment (breast cancer, digestive cancer, gynecological)
- Patient wishing to quit smoking
- Fagerström > 3
- Patient has valid health insurance
- Information and agreement of the patient to participate in the longitudinal cohort
- Signing of specific informed consent for patients in groups 1 to 4 before any study-related intervention
- Person able to speak, read and understand French
Who cannot take part
- Patient not receiving surgical treatment
- Refusal to participate in the longitudinal cohort study
- Pregnant or likely to be pregnant or nursing patient
- Persons deprived of their liberty, under a measure of safeguard of justice, under guardianship or placed under the authority of a guardian
- disability to undergo the medical follow-up of the trial for geographical, social or psychological reasons
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This trial offers support and assistance to patients wishing to quit smoking in order to increase the success rate of smoking cessation and all the benefits associated with it. Patients will be monitored by a tobacco specialist and will be able to benefit from one or more therapies complementary to Nicotine Replacement Therapy (NRT): Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy.
The 4 groups in the trial
- Group 1:Nicotine Replacement Therapy (NRT)Existing treatment, for comparison
Patients enrolled in group 1 will receive a Nicotine Replacement Therapy (NRT) from the study entry to end of study
Treatment: Nicotine Replacement Therapy (NRT)
- Group 2:Motivational Interviewing (MI)Treatment being tested
Patients enrolled in group 2 will receive a Nicotine Replacement Therapy (NRT) from the study entry to end of study and 1 to 3 Motivational Interviewing (MI) after randomization
Treatment: Motivational Interviewing (MI) and Nicotine Replacement Therapy (NRT)
- Group 3:Cognitive Behavioural Therapy (CBT)Treatment being tested
Patients enrolled in group 3 will receive a Nicotine Replacement Therapy (NRT) from the study entry to end of study and 1 to 3 Motivational Interviewing (MI) after randomization and 6 sessions of CBT after Motivational Interviewing up to 6 months after
Treatment: Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT), and Nicotine Replacement Therapy (NRT)
- Group 4: HypnotherapyTreatment being tested
Patients enrolled in group 4 will receive a Nicotine Replacement Therapy (NRT) from the study entry to end of study and 1 to 3 Motivational Interviewing (MI) after randomization and about 3 sessions of hypnotherapy up to 6 months after
Treatment: Motivational Interviewing (MI), Hypnotherapy, and Nicotine Replacement Therapy (NRT)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pilot Study in Cancer Patients Scheduled for Surgery Evaluating Different Smoking Cessation Protocols : Nicotine Replacement (NRT), Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy
- Record updated
- 7 August 2026